- Home
- EMCG vs TTOO Comparison
EMCG vs TTOO Comparison
Compare EMCG & TTOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMCG
- TTOO
- Stock Information
- Founded
- EMCG 2021
- TTOO 2006
- Country
- EMCG United States
- TTOO United States
- Employees
- EMCG N/A
- TTOO N/A
- Industry
- EMCG
- TTOO Medical/Dental Instruments
- Sector
- EMCG
- TTOO Health Care
- Exchange
- EMCG NYSE
- TTOO Nasdaq
- Market Cap
- EMCG 83.7M
- TTOO 36.4M
- IPO Year
- EMCG 2022
- TTOO 2014
- Fundamental
- Price
- EMCG $11.60
- TTOO $0.97
- Analyst Decision
- EMCG
- TTOO Hold
- Analyst Count
- EMCG 0
- TTOO 1
- Target Price
- EMCG N/A
- TTOO $5.00
- AVG Volume (30 Days)
- EMCG 3.2K
- TTOO 710.5K
- Earning Date
- EMCG 01-01-0001
- TTOO 11-13-2024
- Dividend Yield
- EMCG N/A
- TTOO N/A
- EPS Growth
- EMCG 186.72
- TTOO N/A
- EPS
- EMCG 0.24
- TTOO N/A
- Revenue
- EMCG N/A
- TTOO $7,164,000.00
- Revenue This Year
- EMCG N/A
- TTOO $50.31
- Revenue Next Year
- EMCG N/A
- TTOO $117.92
- P/E Ratio
- EMCG $48.18
- TTOO N/A
- Revenue Growth
- EMCG N/A
- TTOO N/A
- 52 Week Low
- EMCG $10.84
- TTOO $0.90
- 52 Week High
- EMCG $13.39
- TTOO $8.38
- Technical
- Relative Strength Index (RSI)
- EMCG 73.32
- TTOO 18.34
- Support Level
- EMCG $11.47
- TTOO $0.90
- Resistance Level
- EMCG $11.62
- TTOO $1.86
- Average True Range (ATR)
- EMCG 0.01
- TTOO 0.15
- MACD
- EMCG 0.01
- TTOO -0.00
- Stochastic Oscillator
- EMCG 84.62
- TTOO 5.72
About EMCG EMBRACE CHANGE ACQUISITION CORP
Embrace Change Acquisition Corp is a blank check company. It is formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses.
About TTOO T2 Biosystems Inc.
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.